Retinoic acid (RA) is a highly conserved, pivotal morphogen that tightly governs pluripotent cell differentiation, neurogenesis, and anterior-posterior axial patterning during embryonic development. To ensure correct lineage commitment, cells must decode the precise spatiotemporal concentration of RA. This transient morphogen gradient is primarily established and maintained through rapid catabolism by the cytochrome P450 enzyme Cyp26a1. While the transcriptional induction of Cyp26a1 by RA is well-documented, the dynamic epigenetic machinery that directly couples RA sensing to robust Cyp26a1 activation remains largely elusive, representing a critical gap in our understanding of early developmental gene regulatory networks.

Here, we identify a highly conserved distal enhancer of Cyp26a1, harboring a functional Retinoic Acid Response Element (RARE), that serves as an essential epigenetic control hub for RA clearance. Using a comprehensive multi-omics approach combined with CRISPR-Cas9 genome engineering in mouse embryonic stem cells (mESCs), we systematically dissected the molecular dynamics of this regulatory axis. Mechanistically, we demonstrate that upon exogenous RA stimulation, RARA/RXRA heterodimers rapidly bind to the RARE within this distal enhancer. Chromatin profiling via CUT&Tag revealed that this direct binding subsequently recruits the histone acetyltransferase P300, which deposits H3K27ac marks at the enhancer region, transitioning it to a highly active epigenetic state. Furthermore, high-resolution chromosome conformation capture (4C-seq) validated that the acetylated enhancer undergoes dynamic structural reorganization, physically looping to contact the Cyp26a1 promoter. This 3D chromatin interaction drives high-level Cyp26a1 transcription, promoting rapid RA catabolism and effectively limiting the duration of the RA signal.

To functionally validate this pathway, we generated mESC lines lacking Cyp26a1, the distal enhancer, or specific RARE elements (RARE-DKO). Time-series bulk and single-cell transcriptomics (scRNA-seq) during directed differentiation revealed that deletion of the enhancer or disruption of the RARE completely abolishes RA-induced Cyp26a1 expression. The resulting sustained, unchecked RA signaling profoundly alters developmental trajectories. Specifically, HOX gene clusters and axial patterning networks fail to activate in proper sequential order. Consequently, pluripotent cells exhibit heavily biased differentiation, prematurely committing toward neuroectoderm-like fates at the severe expense of definitive endoderm and mesoderm lineages. Crucially, pharmacological inhibition of P300 catalytic activity robustly phenocopied the enhancer knockout defects, confirming that P300-mediated epigenetic remodeling is the indispensable linchpin of this negative feedback loop.

Collectively, our findings delineate the RARA/RXRA–RARE–P300–H3K27ac axis as a fundamental epigenetic switch that encodes RA clearance. This regulatory module operates as an autonomous timer, ensuring precise spatiotemporal activation of axial programs and directing pluripotent cells along correct fate trajectories. This study uncovers a novel paradigm wherein morphogen degradation is directly integrated with epigenetic lineage specification, offering profound mechanistic insights into developmental plasticity and revealing potential targets for guided stem cell differentiation in regenerative medicine.